Precision Medicine Market, By Technology (Bioinformatics, Gene Sequencing, Drug Discovery, Precision Molecular Diagnostics, and Big Data Analytics), By Application (Oncology (Breast cancers, Lung Cancer and Others), Central Nervous System, Hematology, Res

Precision Medicine Market, By Technology (Bioinformatics, Gene Sequencing, Drug Discovery, Precision Molecular Diagnostics, and Big Data Analytics), By Application (Oncology (Breast cancers, Lung Cancer and Others), Central Nervous System, Hematology, Respiratory, Immunology, and Others)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Precision medicine guides disease diagnosis, treatment, and prevention of cancer, hereditary diseases, and other disorders based on an individual's unique clinical, molecular, and lifestyle information. Doctors and researchers will be able to predict more accurately which treatment and prevention methods for a specific disease will work in which groups of people using this approach. Through the use of pharmacogenomics, which analyses patient data to guide effective and safe medication plans for patients, precision medicine has the potential to enhance population health and lower overall healthcare costs. The detailed characterization of human biology is now possible owing to innovations in biomarkers, bioimaging, and wearable technologies. Clinicians employ a combination of genomic data, health records, lab tests, and other patient data to help personalise therapy in precision medicine. In this way they will be able to offer the appropriate treatment to the appropriate patient at the appropriate time.
Market Dynamics
The increasing adoption of inorganic strategies such as collaborations and partnerships by the key players in the market is expected to drive the global precision medicine market over the forecast period. For instance, in September 2020, Thermo Fisher Scientific Inc., the world leader in serving science, announced new collaborations of the Thermo Fisher Precision Medicine Science Center (PMSC) with AstraZeneca, a multinational pharmaceutical and Biotechnology Company, and the University of Nebraska Medical Center, a public medical school in Omaha, Nebraska. The new collaboration will help strengthen the PMSC's mission of creating standardized workflows with pharma and academic partners to create new opportunities for precision medicine.
Key features of the study:
This report provides an in-depth analysis of the global precision medicine market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global precision medicine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Intomics, GENinCode, NanoString, Tepnel Pharma Services Limited, Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc, QIAGEN, Quest Diagnostics Incorporated, Medtronic, Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, bioMérieux SA, F. Hoffmann-La Roche Ltd, Eli Lilly & Company, GlaxoSmithKline plc, Cepheid, AstraZeneca PLC, Myriad Genetics, Inc., Bristol-Myers Squibb Company, and Foundation Medicine, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global precision medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global precision medicine market
Detailed Segmentation:
Global Precision Medicine Market, By Technology:
Bioinformatics
Gene Sequencing
Drug Discovery
Precision Molecular Diagnostics
Big Data Analytics
Global Precision Medicine Market, By Application:
Oncology
Breast Cancer
Lung Cancer
Others
Central Nervous System
Hematology
Respiratory
Immunology
Others
Global Precision Medicine Market, By Region:
North America
By Technology
Bioinformatics
Gene Sequencing
Drug Discovery
Precision Molecular Diagnostics
Big Data Analytics
By Application
Oncology
Breast Cancer
Lung Cancer
Others
Central Nervous System
Hematology
Respiratory
Immunology
Others
By Country
U.S.
Canada
Latin America
By Technology
Bioinformatics
Gene Sequencing
Drug Discovery
Precision Molecular Diagnostics
Big Data Analytics
By Application
Oncology
Breast Cancer
Lung Cancer
Others
Central Nervous System
Hematology
Respiratory
Immunology
Others
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Technology
Bioinformatics
Gene Sequencing
Drug Discovery
Precision Molecular Diagnostics
Big Data Analytics
By Application
Oncology
Breast Cancer
Lung Cancer
Others
Central Nervous System
Hematology
Respiratory
Immunology
Others
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Technology
Bioinformatics
Gene Sequencing
Drug Discovery
Precision Molecular Diagnostics
Big Data Analytics
By Application
Oncology
Breast Cancer
Lung Cancer
Others
Central Nervous System
Hematology
Respiratory
Immunology
Others
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Technology
Bioinformatics
Gene Sequencing
Drug Discovery
Precision Molecular Diagnostics
Big Data Analytics
By Application
Oncology
Breast Cancer
Lung Cancer
Others
Central Nervous System
Hematology
Respiratory
Immunology
Others
By Country
GCC
Israel
Rest of Middle East
Africa
By Technology
Bioinformatics
Gene Sequencing
Drug Discovery
Precision Molecular Diagnostics
Big Data Analytics
By Application
Oncology
Breast Cancer
Lung Cancer
Others
Central Nervous System
Hematology
Respiratory
Immunology
Others
By Region/Country
South Africa
Central Africa
North Africa
Company Profiles
Intomics
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
GENinCode
NanoString
Tepnel Pharma Services Limited
Pfizer Inc.
Novartis AG
Teva Pharmaceutical Industries Ltd.
Merck & Co., Inc
QIAGEN
Quest Diagnostics Incorporated
Medtronic
Thermo Fisher Scientific Inc.
Laboratory Corporation of America Holdings
bioMérieux SA
F. Hoffmann-La Roche Ltd
Eli Lilly & Company
GlaxoSmithKline plc
Cepheid
AstraZeneca PLC
Myriad Genetics, Inc.
Bristol-Myers Squibb Company
Foundation Medicine, Inc.
“*” marked represents similar segmentation in other categories in the respective section.